Anupriya Aggarwal Selected Research

Immunoglobulin G (IgG)

4/2024	Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.
4/2023	Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
1/2023	Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses.
10/2022	SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anupriya Aggarwal Research Topics

Disease

15	Infections 04/2024 - 04/2014
14	COVID-19 12/2023 - 12/2020
3	Reinfection 04/2024 - 01/2022
2	Breakthrough Infections 01/2023 - 10/2022
1	Cross Infection (Nosocomial Infection) 11/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 10/2023
1	Exophthalmos (Proptosis) 09/2023
1	Graves Disease (Basedow Disease) 09/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Lymphopenia (Lymphocytopenia) 11/2022
1	HIV Infections (HIV Infection) 01/2017

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 11/2023 - 11/2021
6	Antiviral Agents (Antivirals)IBA 12/2023 - 12/2020
5	AntigensIBA 04/2024 - 01/2021
4	Immunoglobulin G (IgG)IBA 04/2024 - 10/2022
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2014
4	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2023 - 10/2022
4	N-(2-cyanoethylene)urea (BA 1)IBA 11/2023 - 10/2022
4	Neutralizing AntibodiesIBA 01/2023 - 01/2021
3	AntibodiesIBA 09/2023 - 01/2021
2	BNT162 VaccineIBA 01/2023 - 10/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2023
2	gallinamide AIBA 01/2022 - 12/2020
2	Cathepsin LIBA 01/2022 - 12/2020
1	Methylprednisolone FDA LinkGeneric 09/2023
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 09/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	CollagenIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	C-Reactive ProteinIBA 11/2022
1	Actins (F Actin)IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 11/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	Dynamins (Dynamin)IBA 01/2017

Therapy/Procedure

1	Therapeutics 12/2023
1	N95 Respirators 10/2023
1	Decompression 09/2023